pharmaceuticals-and-healthcare

Global Opioid-Induced Constipation Market Insights, Forecast to 2025


Published On : Aug 2018

Category : Pharmaceutical

No. of Pages : 104 pages

  • $3900
  • $7800

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
This report studies the global market size of Opioid-Induced Constipation in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Opioid-Induced Constipation in these regions.
This research report categorizes the global Opioid-Induced Constipation market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation. Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation.
The opioid analgesics produce analgesia by the activation of the mu receptors found in the CNS and PNS. These drugs affect the motility, tone, and contractility of the bowel functions, which results in the delay in the transit of fecal contents. The opioids also cause a reduction in the secretion of digestive enzymes and also cause partial gastroparesis. Some of the common symptoms of opioid-induced constipation are hard and dry stools, painful defecation, bloating, distention and bulged abdomen, feeling lethargic, and loss of appetite.
In 2017, the global Opioid-Induced Constipation market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Opioid-Induced Constipation market based on company, product type, application and key regions.

The various contributors involved in the value chain of Opioid-Induced Constipation include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Opioid-Induced Constipation include
AstraZeneca
Takeda Pharmaceutical
Valeant Pharmaceuticals International
Abbott
Bayer
Boehringer Ingelheim
C.B. Fleet
Cosmo Pharmaceuticals
Daewoong
Daiichi Sankyo
GlaxoSmithKline
Ironwood Pharmaceuticals
Johnson & Johnson
Merck
Mundipharma
Nektar Therapeutics
Pfizer
Progenics Pharmaceuticals
Shionogi
SLA Pharma
Sucampo
Synergy Pharmaceuticals
Theravance

Market Size Split by Type
Solid
Liquid
Market Size Split by Application
Drugstore
Hospital
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Opioid-Induced Constipation market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Opioid-Induced Constipation market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Opioid-Induced Constipation manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Opioid-Induced Constipation with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Opioid-Induced Constipation submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Opioid-Induced Constipation are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Opioid-Induced Constipation market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

In the recent times, the global market for Global opioid induced constipation market insights forecast to 2025 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Global opioid induced constipation market insights forecast to 2025 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Global opioid induced constipation market insights forecast to 2025 production processes, which is also reflecting positively on the growth of this market.

The research report on the Global opioid induced constipation market insights forecast to 2025 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Global opioid induced constipation market insights forecast to 2025 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Global opioid induced constipation market insights forecast to 2025, including the definition, classification, and industry chain structure of Global opioid induced constipation market insights forecast to 2025, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Global opioid induced constipation market insights forecast to 2025.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Global opioid induced constipation market insights forecast to 2025 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Global opioid induced constipation market insights forecast to 2025, implemented in each of the geographical segments. The predominant applications of the Global opioid induced constipation market insights forecast to 2025 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Global opioid induced constipation market insights forecast to 2025 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Global opioid induced constipation market insights forecast to 2025 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Picture of Opioid-Induced Constipation
Figure Global Opioid-Induced Constipation Production (MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Opioid-Induced Constipation Production Market Share by Types (Product Category) in 2017
Figure Solid Product Picture
Table Major Manufacturers of Solid
Figure Liquid Product Picture
Table Major Manufacturers of Liquid
Table Global Opioid-Induced Constipation Market Size Growth Rate by Application 2018-2025 (MT)
Figure Drugstore
Figure Hospital
Figure Others
Figure Opioid-Induced Constipation Report Years Considered
Figure Global Opioid-Induced Constipation Market Size 2016-2025 (Million US$)
Figure Global Opioid-Induced Constipation Sales 2016-2025 (MT)
Table Global Opioid-Induced Constipation Market Size by Regions 2016-2025 (MT) & (Million US$)
Table Global Opioid-Induced Constipation Sales by Regions 2016-2025 (MT)
Table Global Opioid-Induced Constipation Sales Market Share by Regions 2016-2025
Figure Global Opioid-Induced Constipation Sales Market Share by Regions 2016-2025
Figure 2017 Global Opioid-Induced Constipation Sales Market Share by Regions
Table Global Opioid-Induced Constipation Revenue by Regions 2016-2025 (Million US$)
Table Global Opioid-Induced Constipation Revenue Market Share by Regions 2016-2025
Figure Global Opioid-Induced Constipation Revenue Market Share by Regions 2016-2025
Figure 2017 Global Opioid-Induced Constipation Revenue Market Share by Regions
Table Global Opioid-Induced Constipation Sales by Manufacturers (2016-2018) (MT)
Table Global Opioid-Induced Constipation Sales Share by Manufacturers (2016-2018)
Figure Global Opioid-Induced Constipation Sales Share by Manufacturers in 2017
Table Opioid-Induced Constipation Revenue by Manufacturers (2016-2018) (Million US$)
Table Opioid-Induced Constipation Revenue Share by Manufacturers (2016-2018)
Figure Opioid-Induced Constipation Value Share by Manufacturers in 2017
Table Global Opioid-Induced Constipation Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Opioid-Induced Constipation Price (2016-2018) (USD/Kg)
Table Opioid-Induced Constipation Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Opioid-Induced Constipation Product Category
Table Date of International Manufacturers Enter into Opioid-Induced Constipation Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Opioid-Induced Constipation Sales by Type (2016-2025) (MT)
Table Global Opioid-Induced Constipation Sales Share by Type (2016-2025)
Figure Global Opioid-Induced Constipation Sales Market Share by Type (2016-2025)
Figure Global Opioid-Induced Constipation Sales Market Share by Type in 2017
Table Global Opioid-Induced Constipation Revenue by Type (2016-2025) (Million US$)
Table Global Opioid-Induced Constipation Revenue Share by Type (2016-2025)
Figure Global Opioid-Induced Constipation Revenue Market Share by Type (2016-2025)
Figure Global Opioid-Induced Constipation Revenue Market Share by Type in 2017
Table Opioid-Induced Constipation Price by Type 2013-2018 (USD/Kg)
Table Global Opioid-Induced Constipation Sales by Application (2016-2025) (MT)
Table Global Opioid-Induced Constipation Sales Share by Application (2016-2025)
Figure Global Sales Opioid-Induced Constipation Market Share by Application (2016-2025)
Figure Global Sales Opioid-Induced Constipation Market Share by Application (2016-2025)
Figure North America Opioid-Induced Constipation Sales Growth Rate 2016-2025 (MT)
Figure North America Opioid-Induced Constipation Revenue Growth Rate 2016-2025 (Million US$)
Table North America Opioid-Induced Constipation Sales by Countries (2016-2025) (MT)
Table North America Opioid-Induced Constipation Sales Market Share by Countries (2016-2025)
Figure 2017 North America Opioid-Induced Constipation Sales Market Share by Countries
Table North America Opioid-Induced Constipation Revenue by Countries (2016-2025) (Million US$)
Table North America Opioid-Induced Constipation Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Opioid-Induced Constipation Revenue Market Share by Countries
Figure United States Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure United States Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure Canada Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure Mexico Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Table North America Opioid-Induced Constipation Sales by Type (2016-2025) (MT)
Table North America Opioid-Induced Constipation Sales Market Share by Type (2016-2025)
Figure 2017 North America Opioid-Induced Constipation Market Share by Type
Table North America Opioid-Induced Constipation Sales by Application (2016-2025) (MT)
Table North America Opioid-Induced Constipation Sales Market Share by Application (2016-2025)
Figure 2017 North America Opioid-Induced Constipation Market Share by Application
Table North America Opioid-Induced Constipation Sales by Company (2016-2018) (MT)
Table North America Opioid-Induced Constipation Sales Market Share by Company (2016-2018)
Figure North America Opioid-Induced Constipation Sales Market Share by Company in 2017
Figure Europe Opioid-Induced Constipation Sales Growth Rate 2016-2025 (MT)
Figure Europe Opioid-Induced Constipation Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Opioid-Induced Constipation Sales by Countries (2016-2025) (MT)
Table Europe Opioid-Induced Constipation Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Opioid-Induced Constipation Sales Market Share by Countries
Table Europe Opioid-Induced Constipation Revenue by Countries (2016-2025) (Million US$)
Table Europe Opioid-Induced Constipation Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Opioid-Induced Constipation Revenue Market Share by Countries
Figure Germany Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure Germany Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (MT)
Figure France Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure France Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (MT)
Figure UK Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure UK Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure Italy Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure Russia Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Opioid-Induced Constipation Sales by Type (2016-2025) (MT)
Table Europe Opioid-Induced Constipation Sales Market Share by Type (2016-2025)
Figure 2017 Europe Opioid-Induced Constipation Market Share by Type
Table Europe Opioid-Induced Constipation Sales by Application (2016-2025) (MT)
Table Europe Opioid-Induced Constipation Sales Market Share by Application (2016-2025)
Figure 2017 Europe Opioid-Induced Constipation Market Share by Application
Table Europe Opioid-Induced Constipation Sales by Company (2016-2018) (MT)
Table Europe Opioid-Induced Constipation Sales Market Share by Company (2016-2018)
Figure Europe Opioid-Induced Constipation Sales Market Share by Company in 2017
Figure Asia Pacific Opioid-Induced Constipation Sales Growth Rate 2016-2025 (MT)
Figure Asia Pacific Opioid-Induced Constipation Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Opioid-Induced Constipation Sales by Countries (2016-2025) (MT)
Table Asia Pacific Opioid-Induced Constipation Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Opioid-Induced Constipation Sales Market Share by Countries
Table Asia Pacific Opioid-Induced Constipation Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Opioid-Induced Constipation Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Opioid-Induced Constipation Revenue Market Share by Countries
Figure China Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure China Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure Japan Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure Korea Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure India Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure India Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure Australia Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure Indonesia Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure Malaysia Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure Philippines Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure Thailand Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure Vietnam Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure Singapore Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Opioid-Induced Constipation Sales by Type (2016-2025) (MT)
Table Asia Pacific Opioid-Induced Constipation Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Opioid-Induced Constipation Market Share by Type
Table Asia Pacific Opioid-Induced Constipation Sales by Application (2016-2025) (MT)
Table Asia Pacific Opioid-Induced Constipation Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Opioid-Induced Constipation Market Share by Application
Table Asia Pacific Opioid-Induced Constipation Sales by Company (2016-2018) (MT)
Table Asia Pacific Opioid-Induced Constipation Sales Market Share by Company (2016-2018)
Figure Asia Pacific Opioid-Induced Constipation Sales Market Share by Company in 2017
Figure Central & South America Opioid-Induced Constipation Sales Growth Rate 2016-2025 (MT)
Figure Central & South America Opioid-Induced Constipation Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Opioid-Induced Constipation Sales by Countries (2016-2025) (MT)
Table Central & South America Opioid-Induced Constipation Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Opioid-Induced Constipation Sales Market Share by Countries
Table Central & South America Opioid-Induced Constipation Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Opioid-Induced Constipation Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Opioid-Induced Constipation Revenue Market Share by Countries
Figure Brazil Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure Brazil Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure Argentina Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Opioid-Induced Constipation Sales by Type (2016-2025) (MT)
Table Central & South America Opioid-Induced Constipation Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Opioid-Induced Constipation Market Share by Type
Table Central & South America Opioid-Induced Constipation Sales by Application (2016-2025) (MT)
Table Central & South America Opioid-Induced Constipation Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Opioid-Induced Constipation Market Share by Application
Table Central & South America Opioid-Induced Constipation Sales by Company (2016-2018) (MT)
Table Central & South America Opioid-Induced Constipation Sales Market Share by Company (2016-2018)
Figure Central & South America Opioid-Induced Constipation Sales Market Share by Company in 2017
Figure Middle East and Africa Opioid-Induced Constipation Sales Growth Rate 2016-2025 (MT)
Figure Middle East and Africa Opioid-Induced Constipation Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Opioid-Induced Constipation Sales by Countries (2016-2025) (MT)
Table Middle East and Africa Opioid-Induced Constipation Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Opioid-Induced Constipation Sales Market Share by Countries
Table Middle East and Africa Opioid-Induced Constipation Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Countries
Figure GCC Countries Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure GCC Countries Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure Turkey Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure Egypt Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Opioid-Induced Constipation Sales Growth Rate (2016-2025) (MT)
Figure South Africa Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Opioid-Induced Constipation Sales by Type (2016-2025) (MT)
Table Middle East and Africa Opioid-Induced Constipation Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Opioid-Induced Constipation Market Share by Type
Table Middle East and Africa Opioid-Induced Constipation Sales by Application (2016-2025) (MT)
Table Middle East and Africa Opioid-Induced Constipation Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Opioid-Induced Constipation Market Share by Application
Table Middle East and Africa Opioid-Induced Constipation Sales by Company (2016-2018) (MT)
Table Middle East and Africa Opioid-Induced Constipation Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Opioid-Induced Constipation Sales Market Share by Company in 2017
Table AstraZeneca Company Details
Table AstraZeneca Opioid-Induced Constipation Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table AstraZeneca Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Opioid-Induced Constipation Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Takeda Pharmaceutical Recent Development
Table Valeant Pharmaceuticals International Company Details
Table Valeant Pharmaceuticals International Opioid-Induced Constipation Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Valeant Pharmaceuticals International Recent Development
Table Abbott Company Details
Table Abbott Opioid-Induced Constipation Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Abbott Recent Development
Table Bayer Company Details
Table Bayer Opioid-Induced Constipation Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Bayer Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Opioid-Induced Constipation Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Boehringer Ingelheim Recent Development
Table C.B. Fleet Company Details
Table C.B. Fleet Opioid-Induced Constipation Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table C.B. Fleet Recent Development
Table Cosmo Pharmaceuticals Company Details
Table Cosmo Pharmaceuticals Opioid-Induced Constipation Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Cosmo Pharmaceuticals Recent Development
Table Daewoong Company Details
Table Daewoong Opioid-Induced Constipation Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Daewoong Recent Development
Table Daiichi Sankyo Company Details
Table Daiichi Sankyo Opioid-Induced Constipation Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Daiichi Sankyo Recent Development
Table GlaxoSmithKline Company Details
Table Ironwood Pharmaceuticals Company Details
Table Johnson & Johnson Company Details
Table Merck Company Details
Table Mundipharma Company Details
Table Nektar Therapeutics Company Details
Table Pfizer Company Details
Table Progenics Pharmaceuticals Company Details
Table Shionogi Company Details
Table SLA Pharma Company Details
Table Sucampo Company Details
Table Synergy Pharmaceuticals Company Details
Table Theravance Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Opioid-Induced Constipation Value Chain
Table Typical Suppliers of Key Opioid-Induced Constipation Raw Material
Table Opioid-Induced Constipation Customers List
Table Opioid-Induced Constipation Sales Channels
Table Opioid-Induced Constipation Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top